血管内皮生长因子-葡聚糖-聚乳酸-羟基乙酸缓释微球的治疗性血管再生实验研究  

Experimental study on therapeutic angiogenesis of sustained release VEGF-dextran-PLGA microspheres

作　　者：刘崇栋 陈锋[1] 徐颖奇 周卫[1] 唐新华[1] 周为民[1] LIU Chongdong;CHEN Feng;XU Yingqi;ZHOU Wei;TANG Xinhua;ZHOU Weimin(Department of Vascular Surgery,the Second Affiliated Hospital of Nanchang University,Nanchang,Jiangxi 330006,China)

机构地区：[1]南昌大学第二附属医院血管外科,江西省南昌市330006

出　　处：《中国动脉硬化杂志》2019年第1期23-28,共6页Chinese Journal of Arteriosclerosis

基　　金：国家自然科学基金项目(81460083);江西省科技厅自然科学基金资助项目(20141BBG70032;20152ACB21026和20142BAB215034)

摘　　要：目的探讨血管内皮生长因子-葡聚糖-聚乳酸-羟基乙酸缓释微球在促进大鼠缺血下肢血管生成的作用。方法制备血管内皮生长因子-葡聚糖-聚乳酸-羟基乙酸微球,扫描电镜观察其形态,采用酶联免疫吸附测定法检测其体外释药性能。将负载血管内皮生长因子-葡聚糖-聚乳酸-羟基乙酸微球纤维蛋白凝胶注射到大鼠缺血下肢肌肉内,1个月后进行组织学和免疫组织化学检测,评价血管再生情况。结果血管内皮生长因子-葡聚糖-聚乳酸-羟基乙酸微球体外释放血管内皮生成因子持续时间超过4周,可显著提高注射部位毛细血管和α-平滑肌肌动蛋白阳性血管的密度,并促进CD34、C-kit和血管内皮生长因子受体2阳性细胞的动员。结论肌肉注射负载血管内皮生长因子-葡聚糖-聚乳酸-羟基乙酸微球的纤维蛋白凝胶是一种较为理想的治疗性血管再生方法。Aim To investigate the effect of recombinant human vascular endothelial growth factor-dextran-polylactic acid-glycolic acid(VEGF-dextran-PLGA) sustained-release microspheres on promoting angiogenesis in ischemic lower limbs of rats.Methods VEGF-dextran-PLGA microspheres were prepared and their morphology was observed by scanning electron microscopy.The drug release properties were determined by ELISA in vitro.The fibrin gel loaded with VEGF-dextran-PLGA microspheres was injected into the ischemic lower limb muscle of rats,and histological and immunohistochemical staining were performed 1 month later to evaluate the angiogenesis.Results VEGF-dextran-PLGA microspheres released VEGF in vitro for more than 4 weeks.They could significantly increase the density of capillaries andα-smooth muscle actin-positive blood vessels at the injection site,and promote the mobilization of CD34,C-kit and VEGFR-2 positive cells.Conclusion Intramuscular injection of fibrin gel loaded with VEGF-dextran-PLGA microspheres is an ideal therapeutic angiogenesis method.

关 键 词：血管内皮生长因子 缓释微球 缺血下肢 血管生成 

分 类 号：R654.4[医药卫生—外科学]